EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients

Carlo J Iasella iD, Stefanie J Hannan, Emily J Lyons, Sophia C Lieber, Antu Das, Dimiter Dimitrov, Wei Li, Melissa Saul iD, Iulia Popescu, Ritchie Koshy, Robin Burke, Braidon Lape und 18 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0309449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Carlo J Iasella und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: COVID-19, Immunization, Passive, COVID-19 Serotherapy, SARS-CoV-2. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Pittsburgh Foundation, David Scaife Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 convalescent plasma (CCP) was one of the first therapies to receive emergency use authorization for management of COVID-19. We assessed the effectiveness of CCP in a propensity-matched analysis, and whether the presence of antibodies in the recipient at the time of treatment or the titer of antibodies in the administered CCP influenced clinical effectiveness. In an inpatient population within a single large health system, a total of 290 CCP patients were matched to 290 controls. While CCP increased titers of anti-SARS-CoV-2 RBD IgG titers post-CCP (p =

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Immunization, PassiveCOVID-19 SerotherapySARS-CoV-2Antibodies, ViralImmunity, HumoralImmunoglobulin GHumansMaleFemaleMiddle AgedAgedHospitalizationAdult

Substanzen

Antibodies, ViralImmunoglobulin G

Autor:innen und Institutionen

  • Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, United States of America.
  • Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
  • Department of Medicine, Aging Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
  • Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
  • Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
  • Department of Pathology, Division of Transfusion Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.

ORCID-Profile: Carlo J Iasella, Melissa Saul, Ioannis Konstantinidis

Förderung

  • NHLBI NIH HHS
  • Pittsburgh Foundation
  • David Scaife Foundation

Zitieren

APA

Iasella, C. J., Hannan, S. J., Lyons, E. J., Lieber, S. C., Das, A., Dimitrov, D., Li, W., Saul, M., Popescu, I., Koshy, R., Burke, R., Lape, B., Brown, M. J., Chen, X., Sembrat, J. C., Devonshire, K., Kitsios, G. D., Konstantinidis, I., Snyder, M. E., …, & McDyer, J. F. (2024). Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients. PLOS ONE. https://doi.org/10.1371/journal.pone.0309449

Vancouver

Iasella CJ, Hannan SJ, Lyons EJ, Lieber SC, Das A, Dimitrov D, et al. Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients. PLOS ONE. 2024. doi:10.1371/journal.pone.0309449

BibTeX
@article{Iasella2024,
  author = {Iasella, Carlo J and Hannan, Stefanie J and Lyons, Emily J and Lieber, Sophia C and Das, Antu and Dimitrov, Dimiter and Li, Wei and Saul, Melissa and Popescu, Iulia and Koshy, Ritchie and Burke, Robin and Lape, Braidon and Brown, Mark J and Chen, Xiaoping and Sembrat, John C and Devonshire, Kaitlyn and Kitsios, Georgios D and Konstantinidis, Ioannis and Snyder, Mark E and Chen, Bill B and Merlo, Christian A and Hager, David N and Kiss, Joseph E and Yazer, Mark H and Wells, Alan H and Morris, Alison and McVerry, Bryan J and McMahon, Deborah K and Triulzi, Darrell J and McDyer, John F},
  title = {Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0309449}
}
Kostenlos starten →